Souzan Najafi (Behzad Baradaran)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Induced Apoptosis

Cell Cycle Arrest

Top Venues

Medical oncology (Northwood, London, England)

Advanced pharmaceutical bulletin

Journal of cellular physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Souzan Najafi, Zohreh Rahimi, Behzad Mansoori, Ali Mohammadi, Fatemeh Mohammadnejad, Mohammad Amini, Ahad Mokhtazadeh, Zahra Asadzadeh, William Chi Shing Cho, Behzad Baradaran
CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell Migration. Advanced pharmaceutical bulletin 13 (3) (2022)
Mina Afrashteh Nour, Fatemeh Kheradmand, Yousef Rasmi, Souzan Najafi
Alpha7 nicotinic acetylcholine receptor expression in Sorafenib-resistant Hepatocellular carcinoma cells. Medical oncology (Northwood, London, England) 39 (11) (2022)
Ali Mohammadi, Behzad Mansoori, Pascal H G Duijf, Elham Safarzadeh, Leila Tebbi, Souzan Najafi, Behrooz Shokouhi, Grith Lykke Sorensen, Uffe Holmskov, Behzad Baradaran
Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration. Journal of cellular physiology 236 (1) (2020)